deferoxamine has been researched along with liproxstatin-1 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kasukabe, T; Kumakura, S; Yamaguchi, Y | 1 |
| Baatarjav, C; Higashi, T; Kamata, R; Karasawa, T; Komada, T; Ohno, N; Sampilvanjil, A; Takahashi, M; Watanabe, S; Yamada, N | 1 |
| Cho, SS; Ki, SH; Kim, KM | 1 |
| An, H; Bao, Y; Huang, D; Shen, N; Wang, K; Yang, J; Yu, F; Zeng, X; Zheng, L; Zhou, W | 1 |
1 review(s) available for deferoxamine and liproxstatin-1
| Article | Year |
|---|---|
Emerging roles of ferroptosis in liver pathophysiology.
Topics: Animals; Antineoplastic Agents; Caffeic Acids; Carcinoma, Hepatocellular; Cycloheximide; Cyclohexylamines; Deferoxamine; Disease Models, Animal; Disease Progression; Fatty Acids, Unsaturated; Ferroptosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Phenylenediamines; Quinoxalines; Reactive Oxygen Species; Reperfusion Injury; Spiro Compounds | 2020 |
3 other study(ies) available for deferoxamine and liproxstatin-1
| Article | Year |
|---|---|
Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis.
Topics: Acetylcysteine; Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Line, Tumor; Cyclohexylamines; Deferoxamine; Dioxolanes; Diterpenes; Drug Synergism; Fibroblasts; Humans; Iron; Mice; Pancreatic Neoplasms; Phenylenediamines; Quinoxalines; Reactive Oxygen Species; Spiro Compounds; Sulfasalazine | 2018 |
Cigarette smoke extract induces ferroptosis in vascular smooth muscle cells.
Topics: Animals; Cell Death; Cell Line; Cyclohexylamines; Deferoxamine; Endothelial Cells; Ferroptosis; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Phenylenediamines; Quinoxalines; Rats; Rats, Sprague-Dawley; Siderophores; Smoke; Spiro Compounds; Tissue Inhibitor of Metalloproteinase-1 | 2020 |
Benefits of Iron Chelators in the Treatment of Parkinson's Disease.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Deferoxamine; Dopaminergic Neurons; Ferric Compounds; Ferroptosis; Humans; Iron Chelating Agents; Iron Overload; Nerve Growth Factor; Neuroprotective Agents; Parkinson Disease, Secondary; Quaternary Ammonium Compounds; Quinoxalines; Rats; Reactive Oxygen Species; Spiro Compounds | 2021 |